Validity of Meta-Analytical Data on Cutaneous Adverse Events with Phosphoinositide 3-Kinase Inhibitors

登录注册会员服务联系我们

Validity of Meta-Analytical Data on Cutaneous Adverse Events with Phosphoinositide 3-Kinase Inhibitors—Reply

Published:2023-10-01 Issue:10 Volume:9 Page:1462
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Jfri Abdulhadi¹²³⁴,Guggina Lauren¹²³

Affiliation:

1. Harvard Medical School, Boston, Massachusetts

2. Department of Dermatology, Brigham and Women’s Hospital, Boston, Massachusetts

3. Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts

4. College of Medicine, King Saud bin Abdulaziz Univer for Health Sciences, Jeddah, Saudi Arabia

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2809038/jamaoncology_jfri_2023_lr_230020_1697125912.11357.pdf

Reference4 articles.

1. Incidence of cutaneous adverse events with phosphoinositide 3-kinase inhibitors as adjuvant therapy in patients with cancer: a systematic review and meta-analysis.;Jfri;JAMA Oncol,2022

2. Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3): a double-blind, randomised, placebo-controlled, phase 3 trial.;Matasar;Lancet Oncol,2021

3. The use of one-stage meta-analytic method based on individual participant data for binary adverse events under the rule of three: a simulation study.;Cheng;PeerJ,2019

4. Correction: pervasive data errors in Abstract, Results, Figure 3, and Table 2.;JAMA Oncol

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP